EPCAM and non-small cell lung carcinoma: In accordance to our findings, in a previously published report, PD-L1 was highly expressed in epithelial (EpCAM positive) CTCs regardless of the type of cancer [45] and was co-expressed with mesenchymal markers in NSCLC CTCs [31,32].